• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.通过分子建模对人凝血因子V的A结构域进行结构研究。
Protein Sci. 1998 Jun;7(6):1317-25. doi: 10.1002/pro.5560070607.
2
Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.组织蛋白酶G和弹性蛋白酶对因子V的蛋白水解作用表明,在精氨酸1545处的切割通过促进因子Xa的结合来优化辅因子功能。
Biochemistry. 1998 Aug 25;37(34):11896-906. doi: 10.1021/bi980520v.
3
Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.凝血因子V中各个活化蛋白C切割位点区域在因子Va失活和因子Xa激活中的重要性。
Eur J Biochem. 1999 Feb;260(1):64-75. doi: 10.1046/j.1432-1327.1999.00137.x.
4
Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains.凝血因子V和VIII C结构域的同源模型:FV和FVIII C2结构域的一种假定膜结合模式。
Blood Cells Mol Dis. 1998 Dec;24(4):448-61. doi: 10.1006/bcmd.1998.0214.
5
The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.凝血因子V的B结构域的C末端区域对于凝血因子V的抗凝活性至关重要。
J Biol Chem. 1998 Jun 26;273(26):16140-5. doi: 10.1074/jbc.273.26.16140.
6
Completed three-dimensional model of human coagulation factor va. Molecular dynamics simulations and structural analyses.人凝血因子Va的完整三维模型。分子动力学模拟与结构分析。
Biochemistry. 2005 Oct 4;44(39):13082-90. doi: 10.1021/bi050891t.
7
Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.多聚蛋白1以高亲和力结合因子V和活化的因子V,并抑制凝血酶生成。
Thromb Haemost. 2008 Dec;100(6):1058-67.
8
Functional properties of recombinant factor V mutated in a potential calcium-binding site.在潜在钙结合位点发生突变的重组因子V的功能特性
Biochemistry. 2004 May 18;43(19):5803-10. doi: 10.1021/bi0361362.
9
Three-dimensional model of coagulation factor Va bound to activated protein C.与活化蛋白C结合的凝血因子Va的三维模型。
Thromb Haemost. 2000 Nov;84(5):849-57.
10
Differential contributions of Glu96, Asp102 and Asp111 to coagulation factor V/Va metal ion binding and subunit stability.谷氨酸96、天冬氨酸102和天冬氨酸111对凝血因子V/Va金属离子结合及亚基稳定性的不同贡献。
Biochem J. 2009 Aug 13;422(2):257-64. doi: 10.1042/BJ20090405.

引用本文的文献

1
Elucidating the complex membrane binding of a protein with multiple anchoring domains using extHMMM.使用 extHMMM 阐明具有多个锚固结构域的蛋白质的复杂膜结合。
PLoS Comput Biol. 2024 Jul 8;20(7):e1011421. doi: 10.1371/journal.pcbi.1011421. eCollection 2024 Jul.
2
Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.通过联合实验和计算方法揭示凝血因子的膜结合模型。
Thromb Haemost. 2021 Sep;121(9):1122-1137. doi: 10.1055/s-0040-1722187. Epub 2021 Jul 2.
3
Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing.通过新一代测序对白细胞介素-10刺激的(M2c)巨噬细胞进行转录组分析。
Immunobiology. 2017 Jul;222(7):847-856. doi: 10.1016/j.imbio.2017.02.006. Epub 2017 Feb 20.
4
Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis.通过定点诱变绘制因子Va上因子Xa结合位点的图谱。
J Biol Chem. 2008 Jul 25;283(30):20805-12. doi: 10.1074/jbc.M802703200. Epub 2008 May 23.
5
The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.活化蛋白C失活的牛因子Va的晶体结构:对辅因子功能的启示
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8918-23. doi: 10.1073/pnas.0403072101. Epub 2004 Jun 7.
6
Progress in the understanding of the protein C anticoagulant pathway.对蛋白C抗凝途径认识的进展。
Int J Hematol. 2004 Feb;79(2):109-16. doi: 10.1532/ijh97.03149.
7
Coagulation factor Va Glu-96-Asp-111: a chelator-sensitive site involved in function and subunit association.凝血因子Va Glu-96-Asp-111:一个参与功能和亚基缔合的螯合剂敏感位点。
Biochem J. 2004 Jan 1;377(Pt 1):141-8. doi: 10.1042/BJ20031205.
8
Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.结构域间工程化二硫键有助于阐明活化蛋白C使凝血因子Va失活的机制。
Protein Sci. 2002 Sep;11(9):2091-101. doi: 10.1110/ps.0210002.
9
Screening the molecular surface of human anticoagulant protein C: a search for interaction sites.筛选人抗凝蛋白C的分子表面:寻找相互作用位点。
J Comput Aided Mol Des. 2001 Jan;15(1):13-27. doi: 10.1023/a:1011158717139.

本文引用的文献

1
Roles of factor Va heavy and light chains in protein and lipid rearrangements associated with the formation of a bovine factor Va-membrane complex.因子Va重链和轻链在与牛因子Va-膜复合物形成相关的蛋白质和脂质重排中的作用。
Biophys J. 1997 Nov;73(5):2638-52. doi: 10.1016/S0006-3495(97)78293-6.
2
Identification and functional requirement of Cu(I) and its ligands within coagulation factor VIII.凝血因子 VIII 中铜(I)及其配体的鉴定与功能需求
J Biol Chem. 1997 Oct 24;272(43):27428-34. doi: 10.1074/jbc.272.43.27428.
3
Protein S alters the active site location of activated protein C above the membrane surface. A fluorescence resonance energy transfer study of topography.蛋白S改变了膜表面上方活化蛋白C的活性位点位置。一项关于拓扑结构的荧光共振能量转移研究。
J Biol Chem. 1997 Oct 3;272(40):25013-21. doi: 10.1074/jbc.272.40.25013.
4
The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.精氨酸306突变为丙氨酸以及精氨酸506突变为谷氨酰胺对活化蛋白C和蛋白S使重组人因子Va失活的影响。
Protein Sci. 1997 Sep;6(9):2016-27. doi: 10.1002/pro.5560060922.
5
Interaction of calcium with native and decarboxylated human factor X. Effect of proteolysis in the autolysis loop on catalytic efficiency and factor Va binding.钙与天然及脱羧人因子X的相互作用。自溶环中蛋白水解对催化效率和因子Va结合的影响。
J Biol Chem. 1997 Aug 29;272(35):22037-45. doi: 10.1074/jbc.272.35.22037.
6
Cleavage requirements for activation of factor V by factor Xa.凝血因子Xa激活凝血因子V的裂解要求。
Eur J Biochem. 1997 Jul 1;247(1):12-20. doi: 10.1111/j.1432-1033.1997.00012.x.
7
Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.人中性粒细胞弹性蛋白酶激活人凝血因子V,但使凝血酶激活的人凝血因子V失活。
Blood. 1997 Aug 1;90(3):1065-74.
8
Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.对活化蛋白C的抵抗作为血栓形成的危险因素:分子机制、实验室研究及临床管理
Semin Hematol. 1997 Jul;34(3):217-34.
9
Coagulation factor V: an old star shines again.凝血因子V:一颗旧星再度闪耀。
Thromb Haemost. 1997 Jul;78(1):427-33.
10
A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin.基于人铜蓝蛋白晶体结构的人凝血因子VIII三聚体A结构域的分子模型。
Blood. 1997 Apr 1;89(7):2413-21.

通过分子建模对人凝血因子V的A结构域进行结构研究。

Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.

作者信息

Villoutreix B O, Dahlbäck B

机构信息

Lund University, The Wallenberg Laboratory, Department of Clinical Chemistry, University Hospital, Malmö, Sweden.

出版信息

Protein Sci. 1998 Jun;7(6):1317-25. doi: 10.1002/pro.5560070607.

DOI:10.1002/pro.5560070607
PMID:9655335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2144041/
Abstract

Factor V (FV) is a large (2,196 amino acids) nonenzymatic cofactor in the coagulation cascade with a domain organization (A1-A2-B-A3-C1-C2) similar to the one of factor VIII (FVIII). FV is activated to factor Va (FVa) by thrombin, which cleaves away the B domain leaving a heterodimeric structure composed of a heavy chain (A1-A2) and a light chain (A3-C1-C2). Activated protein C (APC), together with its cofactor protein S (PS), inhibits the coagulation cascade via limited proteolysis of FVa and FVIIIa (APC cleaves FVa at residues R306, R506, and R679). The A domains of FV and FVIII share important sequence identity with the plasma copper-binding protein ceruloplasmin (CP). The X-ray structure of CP and theoretical models for FVIII have been recently reported. This information allowed us to build a theoretical model (994 residues) for the A domains of human FV/FVa (residues 1-656 and 1546-1883). Structural analysis of the FV model indicates that: (a) the three A domains are arranged in a triangular fashion as in the case of CP and the organization of these domains should remain essentially the same before and after activation; (b) a Type II copper ion is located at the A1-A3 interface; (c) residues R306 and R506 (cleavage sites for APC) are both solvent exposed; (d) residues 1667-1765 within the A3 domain, expected to interact with the membrane, are essentially buried; (e) APC does not bind to FVa residues 1865-1874. Several other features of factor V/Va, like the R506Q and A221V mutations; factor Xa (FXa) and human neutrophil elastase (HNE) cleavages; protein S, prothrombin and FXa binding, are also investigated.

摘要

因子V(FV)是凝血级联反应中的一种大型(2196个氨基酸)非酶辅因子,其结构域组织(A1-A2-B-A3-C1-C2)与因子VIII(FVIII)相似。FV被凝血酶激活为因子Va(FVa),凝血酶会切除B结构域,留下由重链(A1-A2)和轻链(A3-C1-C2)组成的异二聚体结构。活化蛋白C(APC)与其辅因子蛋白S(PS)一起,通过对FVa和FVIIIa进行有限的蛋白水解来抑制凝血级联反应(APC在R306、R506和R679位点切割FVa)。FV和FVIII的A结构域与血浆铜结合蛋白铜蓝蛋白(CP)具有重要的序列同源性。最近报道了CP的X射线结构和FVIII的理论模型。这些信息使我们能够构建人FV/FVa的A结构域(第1-656位和第1546-1883位氨基酸)的理论模型(994个氨基酸)。FV模型的结构分析表明:(a)三个A结构域呈三角形排列,与CP的情况相同,并且这些结构域在激活前后的组织基本保持不变;(b)一个II型铜离子位于A1-A3界面;(c)R306和R506位点(APC的切割位点)均暴露于溶剂中;(d)预计与膜相互作用的A3结构域内的第1667-1765位氨基酸基本上被掩埋;(e)APC不与FVa的第1865-1874位氨基酸结合。还研究了因子V/Va的其他几个特征,如R506Q和A221V突变;因子Xa(FXa)和人中性粒细胞弹性蛋白酶(HNE)的切割;蛋白S、凝血酶原和FXa的结合。